Clinical Trial

A Study of SH006 Injection Combination Therapy in Patients With Advanced Solid Tumors

Name: A Study of SH006 Injection Combination Therapy in Patients With Advanced Solid Tumors — clinical trial record (NCT07362264)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

To evaluate the safety and tolerability of the combination therapy of SH006 injection in patients with advanced solid tumors

Trial Details

NCT Number	NCT07362264
Lead Sponsor	Nanjing Sanhome Pharmaceutical, Co., Ltd.
Conditions	Liver Cancer
Enrollment	50 participants
Start Date	2025-07-01
Primary Completion	2026-12-30 (estimated)
Study Completion	2028-12-30 (estimated)
Updated on ClinicalTrials.gov	2026-01-23